Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies.

Mahmoodi BK, Cushman M, Anne Næss I, Allison MA, Jan Bos W, Brækkan SK, Cannegieter SC, Gansevoort RT, Gona PN, Hammerstrøm J, Hansen JB, Heckbert S, Holst AG, Lakoski SG, Lutsey PL, Manson JE, Martin LW, Matsushita K, Meijer K, Overvad K, Prescott E, Puurunen M, Rossouw JE, Sang Y, Severinsen MT, Ten Berg J, Folsom AR, Zakai NA.

Circulation. 2017 Jan 3;135(1):7-16. doi: 10.1161/CIRCULATIONAHA.116.024507. Epub 2016 Nov 9. Erratum in: Circulation. 2017 Mar 21;135(12 ):e788.

PMID:
27831499
2.

Interaction of Hereditary Thrombophilia and Traditional Cardiovascular Risk Factors on the Risk of Arterial Thromboembolism: Pooled Analysis of Four Family Cohort Studies.

Mahmoodi BK, Veeger NJ, Middeldorp S, Lijfering WM, Brouwer JL, Ten Berg J, Hamulyák K, Meijer K.

Circ Cardiovasc Genet. 2016 Feb;9(1):79-85. doi: 10.1161/CIRCGENETICS.115.001211. Epub 2015 Dec 17.

3.

A Systematic Review and Meta-Analysis of Long-Term Outcomes After Septal Reduction Therapy in Patients With Hypertrophic Cardiomyopathy.

Liebregts M, Vriesendorp PA, Mahmoodi BK, Schinkel AF, Michels M, ten Berg JM.

JACC Heart Fail. 2015 Nov;3(11):896-905. doi: 10.1016/j.jchf.2015.06.011. Epub 2015 Oct 7. Review.

PMID:
26454847
4.

Kidney measures with diabetes and hypertension on cardiovascular disease: the Atherosclerosis Risk in Communities Study.

Alexander N, Matsushita K, Sang Y, Ballew S, Mahmoodi BK, Astor BC, Coresh J.

Am J Nephrol. 2015;41(4-5):409-17. doi: 10.1159/000433450. Epub 2015 Jun 30.

5.

Initial experience with therapeutic geometric modification of the carotid bulb for true resistant hypertension.

Habib N, Mahmoodi BK, Bos WJ, Tromp SC, Suttorp MJ, Bates MC, Van der Heyden J.

EuroIntervention. 2015 May;11(1):117-20. doi: 10.4244/EIJV11I1A20.

6.

Association of kidney disease measures with ischemic versus hemorrhagic strokes: pooled analyses of 4 prospective community-based cohorts.

Mahmoodi BK, Yatsuya H, Matsushita K, Sang Y, Gottesman RF, Astor BC, Woodward M, Longstreth WT Jr, Psaty BM, Shlipak MG, Folsom AR, Gansevoort RT, Coresh J.

Stroke. 2014 Jul;45(7):1925-31. doi: 10.1161/STROKEAHA.114.004900. Epub 2014 May 29.

7.

Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar.

Wen CP, Matsushita K, Coresh J, Iseki K, Islam M, Katz R, McClellan W, Peralta CA, Wang H, de Zeeuw D, Astor BC, Gansevoort RT, Levey AS, Levin A; Chronic Kidney Disease Prognosis Consortium..

Kidney Int. 2014 Oct;86(4):819-27. doi: 10.1038/ki.2013.553. Epub 2014 Feb 12.

8.

Cystatin C versus creatinine in determining risk based on kidney function.

Shlipak MG, Matsushita K, Ärnlöv J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, Levey AS, Gansevoort RT; CKD Prognosis Consortium..

N Engl J Med. 2013 Sep 5;369(10):932-43. doi: 10.1056/NEJMoa1214234.

9.

Association of chronic kidney disease with adverse outcomes - Authors' reply.

Mahmoodi BK, Fox CS, Astor BC, Nelson RG, Matsushita K, Coresh J; Chronic Kidney Disease Prognosis Consortium..

Lancet. 2013 Feb 16;381(9866):532-3. doi: 10.1016/S0140-6736(13)60273-1. No abstract available.

10.

Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis.

Nitsch D, Grams M, Sang Y, Black C, Cirillo M, Djurdjev O, Iseki K, Jassal SK, Kimm H, Kronenberg F, Oien CM, Levey AS, Levin A, Woodward M, Hemmelgarn BR; Chronic Kidney Disease Prognosis Consortium..

BMJ. 2013 Jan 29;346:f324. doi: 10.1136/bmj.f324. Review.

11.

Cohort profile: the chronic kidney disease prognosis consortium.

Matsushita K, Ballew SH, Astor BC, Jong PE, Gansevoort RT, Hemmelgarn BR, Levey AS, Levin A, Wen CP, Woodward M, Coresh J; Chronic Kidney Disease Prognosis Consortium..

Int J Epidemiol. 2013 Dec;42(6):1660-8. doi: 10.1093/ije/dys173. Epub 2012 Dec 12.

PMID:
23243116
12.

Age and association of kidney measures with mortality and end-stage renal disease.

Hallan SI, Matsushita K, Sang Y, Mahmoodi BK, Black C, Ishani A, Kleefstra N, Naimark D, Roderick P, Tonelli M, Wetzels JF, Astor BC, Gansevoort RT, Levin A, Wen CP, Coresh J; Chronic Kidney Disease Prognosis Consortium..

JAMA. 2012 Dec 12;308(22):2349-60.

13.

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis.

Fox CS, Matsushita K, Woodward M, Bilo HJ, Chalmers J, Heerspink HJ, Lee BJ, Perkins RM, Rossing P, Sairenchi T, Tonelli M, Vassalotti JA, Yamagishi K, Coresh J, de Jong PE, Wen CP, Nelson RG; Chronic Kidney Disease Prognosis Consortium..

Lancet. 2012 Nov 10;380(9854):1662-73. doi: 10.1016/S0140-6736(12)61350-6. Epub 2012 Sep 24. Review. Erratum in: Lancet. 2013 Feb 2;381(9864):374.

14.

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis.

Mahmoodi BK, Matsushita K, Woodward M, Blankestijn PJ, Cirillo M, Ohkubo T, Rossing P, Sarnak MJ, Stengel B, Yamagishi K, Yamashita K, Zhang L, Coresh J, de Jong PE, Astor BC; Chronic Kidney Disease Prognosis Consortium..

Lancet. 2012 Nov 10;380(9854):1649-61. doi: 10.1016/S0140-6736(12)61272-0. Epub 2012 Sep 24. Review. Erratum in: Lancet. 2012 Nov 10;380(9854):1648.

15.

Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohorts.

Mahmoodi BK, Gansevoort RT, Næss IA, Lutsey PL, Brækkan SK, Veeger NJ, Brodin EE, Meijer K, Sang Y, Matsushita K, Hallan SI, Hammerstrøm J, Cannegieter SC, Astor BC, Coresh J, Folsom AR, Hansen JB, Cushman M.

Circulation. 2012 Oct 16;126(16):1964-71. doi: 10.1161/CIRCULATIONAHA.112.113944. Epub 2012 Sep 13.

16.

Lipid levels do not influence the risk of venous thromboembolism. Results of a population-based cohort study.

van Schouwenburg IM, Mahmoodi BK, Gansevoort RT, Muntinghe FL, Dullaart RP, Kluin-Nelemans HC, Veeger NJ, Meijer K.

Thromb Haemost. 2012 Nov;108(5):923-9. doi: 10.1160/TH12-06-0426. Epub 2012 Sep 5.

PMID:
22955992
17.

Increased risk of arterial thromboembolism after a prior episode of venous thromboembolism: results from the Prevention of REnal and Vascular ENd stage Disease (PREVEND) Study.

van Schouwenburg IM, Gansevoort RT, Mahmoodi BK, Visser MM, Kluin-Nelemans HC, Lijfering WM, Veeger NJ.

Br J Haematol. 2012 Oct;159(2):216-22. doi: 10.1111/bjh.12005. Epub 2012 Aug 24.

PMID:
22924556
18.

Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate.

Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH, Polkinghorne KR, Shankar A, Smith DH, Tonelli M, Warnock DG, Wen CP, Coresh J, Gansevoort RT, Hemmelgarn BR, Levey AS; Chronic Kidney Disease Prognosis Consortium..

JAMA. 2012 May 9;307(18):1941-51. doi: 10.1001/jama.2012.3954.

19.

Insulin resistance and risk of venous thromboembolism: results of a population-based cohort study.

Van Schouwenburg IM, Mahmoodi BK, Veeger NJ, Bakker SJ, Kluin-Nelemans HC, Meijer K, Gansevoort RT.

J Thromb Haemost. 2012 Jun;10(6):1012-8. doi: 10.1111/j.1538-7836.2012.04707.x.

20.

Elevated albuminuria associated with increased risk of recurrent venous thromboembolism: results of a population-based cohort study.

van Schouwenburg IM, Mahmoodi BK, Veeger NJ, Kluin-Nelemans HC, Gansevoort RT, Meijer K.

Br J Haematol. 2012 Mar;156(5):667-71. doi: 10.1111/j.1365-2141.2011.09018.x. Epub 2012 Jan 11.

PMID:
22233096

Supplemental Content

Loading ...
Support Center